Showing results (691-700 of 1,008) with videos related to
Sort By:
Pageof 101
Cardiovascular Therapeutics|February 9, 2017
The Tasmanian atrial fibrillation study: Transition to direct oral anticoagulants 2011-2015Endalkachew Admassie Alamneh, Leanne Chalmers, Luke R BereznickiCardiovascular Therapeutics|January 1, 2017
Effective suppression of atrial fibrillation by the antihistaminic agent antazoline: First experimental insights into a novel antiarrhythmic agentGerrit Frommeyer, Magdalena Sterneberg, Dirk G Dechering, et al.Cardiovascular Therapeutics|January 1, 2017
Epac-Rap1-activated mesenchymal stem cells improve cardiac function in rat model of myocardial infarctionIrfan Khan, Anwar Ali, Muhammad Aleem Akhter, et al.Cardiovascular Therapeutics|January 1, 2017
Hydrochlorothiazide modulates ischemic heart failure-induced cardiac remodeling via inhibiting angiotensin II type 1 receptor pathway in ratsJinghong Luo, Xuanlan Chen, Chufan Luo, et al.Cardiovascular Therapeutics|November 29, 2016
Photodynamic therapy for the treatment of atherosclerotic plaque: Lost in translation?Manish Jain, Matthieu Zellweger, Georges Wagnières, et al.Cardiovascular Therapeutics|October 12, 2016
Serelaxin in acute heart failure: Most recent update on clinical and preclinical evidenceRaktim Kumar Ghosh, Kinjal Banerjee, Ramyashree Tummala, et al.Cardiovascular Therapeutics|February 28, 2014
The role of homocysteine-lowering B-vitamins in the primary prevention of cardiovascular diseaseBalazs Debreceni, Laszlo DebreceniCardiovascular Therapeutics|April 20, 2017
Ivabradine vs metoprolol in patients with acute inferior wall myocardial infarction-"Expanding arena for ivabradine"Kumari Priti, Bhanwar L Ranwa, Rajendra K Gokhroo, et al.Cardiovascular Therapeutics|April 20, 2017
Assessment of vascular response to BiOSS LIM C® stents vs Orsiro® stents in the porcine coronary artery modelJacek Bil, Robert J Gil, Tomasz Pawlowski, et al.Cardiovascular Therapeutics|October 26, 2018
Management of arterial hypertension with angiotensin receptor blockers: Current evidence and the role of olmesartanStefano Omboni, Massimo VolpePageof 101